GI Dynamics has announced that the new data on its novel non-invasive device to treat obesity and type 2 diabetes, EndoBarrier™, currently in the clinical trial phase, will be presented soon. The EndoBarrier Gastrointestinal Liner will be a new sign of hope for the 99% of patients qualified as clinically obese and do not want to go for bariatric surgery. The data will be put forward at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress in Buenos Aires, Argentina.

As evidence of Britain’s childhood obesity crisis, a study showed that a quarter of five-year-olds and more than a third of 11-year-olds are overweight. The statistics were derived from a study in which approximately 800,000 children were weighed and measured in the National Child Measurement Programme (NCMP) conducted by the NHS Information Centre. Officials indicated that the statistics may be on the lower side, since the government’s weighing program in primary schools is voluntary and the most obese children might not have participated.